Grand Rapids cancer patients who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain will have an additional drug to use for the management of breakthrough pain – Lazanda (Fentanyl) nasal spray.

Archimedes Pharma Ltd. and its subsidiary, Archimedes Pharma U.S. Inc., announced the U.S. Food and Drug Administration, FDA, granted approval for the use of Lazanda (Fentanyl) nasal spray for the management of breakthrough pain in cancer patients 18 years of age and older.

Lazanda is marketed as PecFent (fentanyl pectin nasal spray) in Europe, where it is presently available in five countries.

According to Jeffrey H. Buchalter, Chief Executive Officer of Archimedes Pharma, “Lazanda is an important new option for patients with cancer who experience excruciating breakthrough pain. Lazanda, which uses our patented PecSys drug delivery system, is designed to deliver medicine in a rapid, but controlled manner, and provides patients with an effective alternative to manage their breakthrough pain.”

Lazanda will be available in the second half of this year through a Risk Evaluation and Mitigation Strategy program, which is intended to minimize the risk of misuse, abuse, addiction, overdose, and serious complications due to medication errors.

Continue reading on Examiner.com FDA approves pain killer Fentanyl in nasal spray form - Grand Rapids public health | Examiner.com http://www.examiner.com/public-health-in-grand-rapids/fda-approves-pain-killer-fentanyl-nasal-spray-form#ixzz1RJskNpYy
Lazanda contains Fentanyl which is a Schedule II controlled substance. The drug is designed to deliver a fine mist spray to a mucus membrane – the nasal membrane. Each spray of Lazanda forms a gel when it contacts the nasal mucosa. The active ingredient is then rapidly absorbed across the mucus membrane and directly into the blood stream.

The most common adverse events associated with Lazanda were consistent with opioid treatment and included vomiting, nausea, fever, and constipation.

Continue reading on Examiner.com FDA approves pain killer Fentanyl in nasal spray form - Grand Rapids public health | Examiner.com http://www.examiner.com/public-health-in-grand-rapids/fda-approves-pain-killer-fentanyl-nasal-spray-form#ixzz1RJss9DAM

Comments

Search RSS

All rights reserved."